Evidence map›Paper›PMID 39999884›Full record

ArticleJournal of the Royal Society, Interface2025

An integrated airborne transmission risk assessment model for respiratory viruses: short- and long-range contributions.

Andre Henriques, Wei Jia, Luis Aleixo, Nicolas Mounet, Luca Fontana, Alice Simniceanu, James Devine, Philip Elson, Gabriella Azzopardi, Markus Rognlien and 5 more

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Heavy metals and pesticides in medicinal plants: environmental sources, plant responses, and human health risk assessment.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  2. The Wells-Riley Model Revisited II: Parameter Uncertainty and Population Heterogeneity.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andre HenriquesCERN (European Organization for Nuclear Research), Geneva, Switzerland.ORCID 0000-0003-1521-3423
Wei JiaDepartment of Mechanical Engineering, University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-7962-1376
Luis AleixoCERN (European Organization for Nuclear Research), Geneva, Switzerland.ORCID 0000-0002-8829-6509
Nicolas MounetCERN (European Organization for Nuclear Research), Geneva, Switzerland.ORCID 0000-0002-1433-1017
Luca FontanaStrategic Health Operations, Operations Support and Logistic, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.ORCID 0000-0002-8614-4114
Alice SimniceanuInstitute of Global Health, University of Geneva, Geneva, Switzerland.ORCID 0000-0003-4068-6177
James DevineCERN (European Organization for Nuclear Research), Geneva, Switzerland.ORCID 0000-0002-2019-1532
Philip ElsonCERN (European Organization for Nuclear Research), Geneva, Switzerland.
Gabriella AzzopardiCERN (European Organization for Nuclear Research), Geneva, Switzerland.ORCID 0000-0001-7257-7827
Markus RognlienCERN (European Organization for Nuclear Research), Geneva, Switzerland.
Marco AndreiniCERN (European Organization for Nuclear Research), Geneva, Switzerland.ORCID 0000-0001-8474-4397
Nicola TaroccoCERN (European Organization for Nuclear Research), Geneva, Switzerland.ORCID 0000-0002-2227-1229
Olivia KeiserInstitute of Global Health, University of Geneva, Geneva, Switzerland.ORCID 0000-0001-8191-2789
Yuguo LiDepartment of Mechanical Engineering, University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-2281-4529
Julian W TangRespiratory Sciences, University of Leicester, Leicester, UK.ORCID 0000-0002-4963-1028

Funding

CERNWorld Health Organization 001
6 · The paper itself

Abstract

This study presents an advanced airborne transmission risk assessment model that integrates both short- and long-range routes in the spread of respiratory viruses, building upon the CERN Airborne Model for Indoor Risk Assessment (CAiMIRA) and aligned with the new World Health Organization (WHO) terminology. Thanks to a two-stage exhaled jet approach, the model accurately simulates short-range exposures, thereby improving infection risk predictions across diverse indoor settings. Key findings reveal that in patient wards, the short-range viral dose is 10-fold higher than the long-range component, highlighting the critical role of close proximity interactions. Implementation of FFP2 respirators resulted in a remarkable 13-fold reduction in viral dose, underscoring the effectiveness of personal protective equipment (PPE). Additionally, the model demonstrated that an 8 h exposure in a poorly ventilated office can equate to the risk of a 15 min face-to-face, mask-less interaction, emphasizing the importance of physical distancing and source control. We also found in high-risk or low-occupancy settings, that secondary transmission is driven more by overall epidemic trends than by the presence of individual superspreaders. Monte Carlo simulations across various scenarios, including classrooms and offices, validate the model's robustness in optimizing infection prevention strategies. These findings support targeted interventions for short- and long-range exposure to reduce airborne transmission.

Indexed as

Air MicrobiologyCOVID-19Models, BiologicalSARS-CoV-2HumansRisk Assessmentairborne transmissionCERN Airborne Model for Indoor Risk AssessmentCOVID-19modellingrespiratory virusrisk assessment

Identifiers

PMID39999884
PMCPMC11858786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.